Trodusquemine: a future treatment for heart disease and diabetic kidney disease?

Written by Mike Gregg

Trodusquemine, developed by Novo Biosciences (ME, US) as a potential regenerative treatment for heart disease and Duchenne muscular dystrophy, has received further grants towards its testing. The breakthrough drug candidate trodusquemine, developed by Novo Biosciences (ME, US) as a potential regenerative treatment for heart disease and Duchenne muscular dystrophy, has continued its path towards the medical marketplace passing all the necessary milestones and receiving further grants towards its testing. The development of trodusquemine comes at an important time as heart disease is the leading cause of death in the US and at present there are very few treatment options available...

To view the full article, please register now for access

It's completely free